NovaBay Pharmaceuticals
15 hedge funds and large institutions have $741K invested in NovaBay Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$220K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$47K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22.7K |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |
